Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects

Published:2020-07-01 Issue:3 Volume:83 Page:185-194
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:en
Short-container-title:Tuberc Respir Dis

Author:

Singh Dave^ORCID

Funder

National Institute for Health Research

Manchester Biomedical Research Centre

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Link

http://www.e-trd.org/upload/pdf/trd-2020-0026.pdf

Reference72 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

2. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease

3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019

4. Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

5. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell viability measured by cytotoxicity assay as a biomarker of chronic obstructive pulmonary disease exacerbation: a prospective cohort study;2024-08-09

2. Correlation of fractional exhaled nitric oxide (FeNO) and clinical outcomes in patients with chronic obstructive pulmonary disease: A prospective cohort study;Respiratory Medicine;2024-08

3. Risk factors of acute exacerbation and disease progression in young patients with COPD;BMJ Open Respiratory Research;2024-07

4. Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study;International Journal of Chronic Obstructive Pulmonary Disease;2024-07

5. Chronisch-obstruktive Lungenerkrankung (COPD) – Eosinophilie und neue Arzneimitteltherapien;Die Innere Medizin;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3